Project Updates
General Practitioners Survey
Are you a general practitioner? Do you have 5 minutes for us? Please complete this survey and help us better understand how we can help you better understand what RDCTs are all about. [...]
Open call for additional technology partners (D6.5)
Open call for additional technology partners (D6.5) Lead Contributors: Nathalie Vigot (UMCU PMO) June 21, 2021 The Trials@Home pan-European pilot (pan-EU pilot) study aims at comparing traditional clinical trial [...]
Public Report Semi-Annual Meeting April 2021
Trials@Home celebrated its annual meeting’s extra spring edition Virtual, 23 June 2021 After nearly 2 years of intense work and study in the field of decentralised clinical trials, more than [...]
Mapping and analysis of the EU legislation on Remote Decentralised Clinical Trials (D4.1)
Mapping and analysis of the EU legislation on Remote Decentralised Clinical Trials including legal, regulatory, ethical and stakeholder recommendations for the conduct of the pan-EU pilot (D4.1) Lead Contributors: Yared Santa-Ana-Tellez, Utrecht University - Helga [...]
Patient Survey
This survey is now closed. If you like to know the results or participate in future surveys, please contact Petra Naster
Request for Proposal
Request for Proposal Submit your technology to Trials@Home Trials@Home (EU/EFPIA Innovative Medicines Initiative - Joint Undertaking (H2020-JTI-IMI2) Trials@Home grant n° 831458) aims to reshape clinical trial design, conduct and [...]
Trials@Home Annual General Meeting 5-6 October 2020 – Public Report
Trials@Home Annual General Meeting Public Report 5-6 October 2020 September 2019, the great and grand kick-off meeting for the Trials@Home project in Paris. A big project, a large group [...]
Detailed list of Quality assessment criteria and assessment procedures (D2.2)
Detailed list of Quality assessment criteria and assessment procedures (D2.2) Lead Contributors: Jaap Trappenburg, Arnela Suman (UMCU) August 25, 2020 This report describes the development of the quality [...]
Criteria for selection of appropriate trials (D1.2)
Criteria for selection of appropriate trials (D1.2) Lead contributors: Giorgia De Paoli / Amy Rogers / Isla Mackenzie (University of Dundee) August 26, 2020 Remote decentralised clinical trial (RDCT) methods [...]
First set of recommendations for RDCTs (D1.1)
First set of recommendations for RDCTs (D1.1) Lead contributors: Amy Rogers / Isla Mackenzie (University of Dundee) August 26, 2020 Clinical trials are a crucial step in the development [...]
EU Remote Trials Project Gets Moving
EU Remote Trials Project Gets Moving Diabetes Pilot Will Compare Conventional & Remote Trial Approaches By Vibha Sharma, Pink Sheet, 29 June 2020 REMOTE TRIALS CAN IMPROVE PATIENT RECRUITMENT AND [...]
First version of Data management plan (D6.3)
First version of Data management plan (D6.3) Lead Contributor: Herman Verheij (Lygature) June 8, 2020 Data Management Plan (DMP) provides a description of the data management that will be [...]
Request for information
Request for information Submit your technology to Trials@Home Trials@Home (EU/EFPIA Innovative Medicines Initiative - Joint Undertaking (H2020-JTI-IMI2) Trials@Home grant n° 831458) aims to reshape clinical trial design, conduct and [...]
Trials@Home Glossary
Glossary Understanding the key terms that will feature in project outputs (updated April 2021) The aim of the glossary is to establish a common language and to aid understanding [...]
Innovative Medicines Initiative Launches ‘Trials@Home’
Innovative Medicines Initiative Launches ‘Trials@Home’ A major European project to bring clinical trials to the participant’s home Utrecht, October 7, 2019 The Trials@Home consortium will explore the opportunities [...]
Ethics D1a, GEN-Requirement: Independent Ethics Advisor appointed to participate in the independent external expert panel (D6.9)
Ethics D1a, GEN-Requirement: Independent Ethics Advisor appointed to participate in the independent external expert panel (D6.9) Lead Contributor: Mira Zuidgeest (UMCU) November 11, 2019 Ethical guidance for the Trials@Home [...]